August 28, 2016 4:52 PM ET

Life Sciences Tools and Services

Company Overview of Promega Corporation

Company Overview

Promega Corporation provides solutions and technical support to the life sciences industry. It offers products for DNA-based human identification that enable scientists to advance their knowledge in genomics, proteomics, cellular analysis, drug discovery, and human identification. The company also provides cell biology products, such as cell health and metabolism, cell line and sample identification, cell signaling, imaging and immunological detection, reporter assays, and transfection solutions; and DNA analysis products, including cloning and DNA markers, DNA purification and quantitation, epigenetics, next-generation sequencing, PCR, and vectors solutions. In addition, it offers drug deve...

2800 Woods Hollow Road

Madison, WI 53711

United States

Founded in 1978





Key Executives for Promega Corporation

Co-Founder, Chairman and Chief Executive Officer
Age: 68
Chief Technical Officer and Vice President
Senior Executive Officer
Age: 64
Vice President of Global Sales
Age: 56
Compensation as of Fiscal Year 2016.

Promega Corporation Key Developments

Genovis Reaches Settlement in Patent Infringement Lawsuit with Promega Corp

Genovis has reached a settlement in its patent infringement lawsuit with Promega Corp. and agreed to a royalty bearing, worldwide license to the patents-in-suit. The settlement ends all ongoing patent-infringement claims between the parties and Promega has agreed to a royalty bearing, worldwide license to the patents-in-suit, thereby ending the lawsuit between the parties.

Promega Corporation's Promega PowerPlex Fusion 6C System Receives Approval by the FBI

Promega Corporation announced that the Promega PowerPlex® Fusion 6C System was granted approval by the FBI for use in laboratories that generate DNA records for the National DNA Index System (NDIS). NDIS, a component of the FBI’s CODIS system, is the U.S. national database containing nearly twelve million offender profiles used by authorities to help solve criminal investigations nationwide. Launched in January 2015, the PowerPlex Fusion 6C System is a 27-locus multiplex that combines common and informative loci, including SE33, Penta D and Penta E, to overcome typical challenges faced by laboratories, such as sample inhibitors, low levels of input DNA and degradation. Unlike other multiplexes, the PowerPlex Fusion 6C System contains three Y-STR loci to improve mixture analysis that is commonly done with crime scene samples. Laboratories can streamline workflow and stretch their budget using the PowerPlex Fusion 6C System because the kit is capable of direct amplification with 12.5µl reactions from numerous sample types, including FTA® cards, nonFTA cards and commonly used swabs. The PowerPlex Fusion 6C System meets CODIS and European standards, allowing laboratories to achieve the most inter-database compatibility and high discrimination of any commercially available autosomal STR kit.

Promega Corporation Announces Launch of NanoBRET Protein Interaction Assays

Promega Corporation announced the launch of NanoBRET Protein Interaction Assays, which use a new Bioluminescence Resonance Energy Transfer (BRET) technology that enables scientists to quantitatively measure protein: protein interactions in live cells. Traditional methods for studying interactions between proteins are commonly performed in vitro using only protein fragments and do not provide data in the context of the cellular environment. With NanoBRET Protein Interaction Assays, researchers can study both induction and inhibition of protein interactions in real time using full-length proteins expressed at physiologically relevant levels. Conventional BRET measures the interaction of proteins using a bioluminescent donor fused to a protein of interest and a fluorescent acceptor fused to its binding partner; the donor does not excite the fluorophore using light, but transfers resonance energy through dipole-dipole coupling. The optimized NanoBRET Protein Interaction Assays use NanoLuc® Luciferase as the energy donor and HaloTag® protein as the energy acceptor. NanoBRET Technology has improved spectral overlap, increased signal, and lower background, providing researchers with a reproducible method for monitoring and screening protein interactions. In addition, the brighter light output from NanoLuc enables use of NanoBRET even at low expression levels, while still providing efficient energy transfer.

Similar Private Companies By Industry

Company Name Region
10X Genomics, Inc. United States
4G Clinical, Inc. United States
AAPharmaSyn LLC United States
Abiant, Inc. United States
aBioBot, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Promega Corporation, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at